降圧薬の世界市場2020-2026:利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬

QYResearchが発行した調査報告書(QYR20AP00111)
◆英語タイトル:Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP00111
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、降圧薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、降圧薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・降圧薬の種類別市場2015-2026:利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬
・降圧薬の用途別市場2015-2026:病院薬局、小売薬局、オンライン薬局
・降圧薬の北米市場分析
・降圧薬のアジア市場分析
・降圧薬の中南米市場分析
・降圧薬の中東・アフリカ市場分析
・関連企業情報:Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、AstraZeneca、Daiichi Sankyo Company Limited、Takeda Pharmaceutical
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

In 2019, the global Anti-Hypertensive Drugs market size was US$ 40270 million and is forecast to US$ 45120 million in 2026, growing at a CAGR of 1.6% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Anti-Hypertensive Drugs.The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Anti-Hypertensive Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Anti-Hypertensive Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Anti-Hypertensive Drugs market. Readers of the report can become informed about current and future trends of the global Anti-Hypertensive Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Anti-Hypertensive Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Anti-Hypertensive Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Anti-Hypertensive Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Anti-Hypertensive Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Anti-Hypertensive Drugs market is segmented into
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors

Market Segment by Application, the Anti-Hypertensive Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report includes the following manufacturers; we can also add the other companies as you want.
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical

The study objectives are:
To analyze and research the global Anti-Hypertensive Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Hypertensive Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Anti-Hypertensive Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Anti-Hypertensive Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Diuretics
1.3.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.3.4 Angiotensin Receptor Blockers (ARBs)
1.3.5 Calcium Channel Blockers
1.3.6 Beta Blockers
1.3.7 Alpha Blockers
1.3.8 Vasodilators
1.3.9 Renin Inhibitors
1.4 Market Segment by Application
1.4.1 Global Anti-Hypertensive Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Anti-Hypertensive Drugs Revenue (2015-2026)
2.1.1 Global Anti-Hypertensive Drugs Revenue (2015-2026)
2.1.2 Global Anti-Hypertensive Drugs Sales (2015-2026)
2.2 Anti-Hypertensive Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Anti-Hypertensive Drugs Sales by Regions (2015-2020)
2.2.2 Global Anti-Hypertensive Drugs Revenue by Regions (2015-2020)
2.3 Global Top Anti-Hypertensive Drugs Regions (Countries) Ranking by Market Size
2.4 Anti-Hypertensive Drugs Industry Trends
2.4.1 Anti-Hypertensive Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Anti-Hypertensive Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Anti-Hypertensive Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Anti-Hypertensive Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Anti-Hypertensive Drugs Sales in 2019
3.2 Global Top Manufacturers Anti-Hypertensive Drugs by Revenue
3.2.1 Global Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Hypertensive Drugs as of 2019)
3.4 Global Anti-Hypertensive Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Anti-Hypertensive Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Anti-Hypertensive Drugs Market
3.7 Key Manufacturers Anti-Hypertensive Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Anti-Hypertensive Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Anti-Hypertensive Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Anti-Hypertensive Drugs Price by Type (2015-2020)
4.1 Global Anti-Hypertensive Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Anti-Hypertensive Drugs Price Forecast by Type (2021-2026)

5 Global Anti-Hypertensive Drugs Market Size by Application
5.1 Global Anti-Hypertensive Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Anti-Hypertensive Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Anti-Hypertensive Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Anti-Hypertensive Drugs Price by Application (2015-2020)
5.2 Global Anti-Hypertensive Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Anti-Hypertensive Drugs Breakdown Data by Company
6.2 North America Anti-Hypertensive Drugs Breakdown Data by Type
6.3 North America Anti-Hypertensive Drugs Breakdown Data by Application
6.4 North America Anti-Hypertensive Drugs Breakdown Data by Countries
6.4.1 North America Anti-Hypertensive Drugs Sales by Countries
6.4.2 North America Anti-Hypertensive Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Anti-Hypertensive Drugs Breakdown Data by Company
7.2 Europe Anti-Hypertensive Drugs Breakdown Data by Type
7.3 Europe Anti-Hypertensive Drugs Breakdown Data by Application
7.4 Europe Anti-Hypertensive Drugs Breakdown Data by Countries
7.4.1 Europe Anti-Hypertensive Drugs Sales by Countries
7.4.2 Europe Anti-Hypertensive Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Anti-Hypertensive Drugs Breakdown Data by Company
8.2 Asia Pacific Anti-Hypertensive Drugs Breakdown Data by Type
8.3 Asia Pacific Anti-Hypertensive Drugs Breakdown Data by Application
8.4 Asia Pacific Anti-Hypertensive Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Anti-Hypertensive Drugs Sales by Regions
8.4.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Anti-Hypertensive Drugs Breakdown Data by Company
9.2 Latin America Anti-Hypertensive Drugs Breakdown Data by Type
9.3 Latin America Anti-Hypertensive Drugs Breakdown Data by Application
9.4 Latin America Anti-Hypertensive Drugs Breakdown Data by Countries
9.4.1 Latin America Anti-Hypertensive Drugs Sales by Countries
9.4.2 Latin America Anti-Hypertensive Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Anti-Hypertensive Drugs Breakdown Data by Type
10.2 Middle East and Africa Anti-Hypertensive Drugs Breakdown Data by Application
10.3 Middle East and Africa Anti-Hypertensive Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Countries
10.3.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novartis Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novartis Anti-Hypertensive Drugs Products and Services
11.1.5 Novartis SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Pfizer Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Pfizer Anti-Hypertensive Drugs Products and Services
11.2.5 Pfizer SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Johnson & Johnson Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products and Services
11.3.5 Johnson & Johnson SWOT Analysis
11.3.6 Johnson & Johnson Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Sanofi Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Sanofi Anti-Hypertensive Drugs Products and Services
11.4.5 Sanofi SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 Lupin
11.5.1 Lupin Corporation Information
11.5.2 Lupin Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Lupin Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Lupin Anti-Hypertensive Drugs Products and Services
11.5.5 Lupin SWOT Analysis
11.5.6 Lupin Recent Developments
11.6 Ranbaxy Laboratories
11.6.1 Ranbaxy Laboratories Corporation Information
11.6.2 Ranbaxy Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products and Services
11.6.5 Ranbaxy Laboratories SWOT Analysis
11.6.6 Ranbaxy Laboratories Recent Developments
11.7 Merck
11.7.1 Merck Corporation Information
11.7.2 Merck Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Merck Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Merck Anti-Hypertensive Drugs Products and Services
11.7.5 Merck SWOT Analysis
11.7.6 Merck Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Business Overview and Total Revenue (2019 VS 2018)
11.8.3 AstraZeneca Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 AstraZeneca Anti-Hypertensive Drugs Products and Services
11.8.5 AstraZeneca SWOT Analysis
11.8.6 AstraZeneca Recent Developments
11.9 Daiichi Sankyo Company Limited
11.9.1 Daiichi Sankyo Company Limited Corporation Information
11.9.2 Daiichi Sankyo Company Limited Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products and Services
11.9.5 Daiichi Sankyo Company Limited SWOT Analysis
11.9.6 Daiichi Sankyo Company Limited Recent Developments
11.10 Takeda Pharmaceutical
11.10.1 Takeda Pharmaceutical Corporation Information
11.10.2 Takeda Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products and Services
11.10.5 Takeda Pharmaceutical SWOT Analysis
11.10.6 Takeda Pharmaceutical Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Anti-Hypertensive Drugs Sales Channels
12.2.2 Anti-Hypertensive Drugs Distributors
12.3 Anti-Hypertensive Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.1.1 Global Anti-Hypertensive Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Anti-Hypertensive Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.2.2 North America Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
13.2.3 North America Anti-Hypertensive Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.3.2 Europe Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Anti-Hypertensive Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Anti-Hypertensive Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Anti-Hypertensive Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Anti-Hypertensive Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Anti-Hypertensive Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Novartis、Pfizer、Johnson & Johnson、Sanofi、Lupin、Ranbaxy Laboratories、Merck、AstraZeneca、Daiichi Sankyo Company Limited、Takeda Pharmaceutical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 降圧薬の世界市場2020-2026:利尿薬、アンジオテンシン変換酵素(ACE)阻害剤、アンジオテンシン受容体遮断薬(ARB)、カルシウムチャネル遮断薬、ベータ遮断薬、アルファ遮断薬、血管拡張薬、レニン阻害薬(Global Anti-Hypertensive Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。